31 Mar 2023
Assets3.87
Total Income0.00
EBITDA-0.01
Profit After Tax-0.01
NET Worth0.37
Reserves and Surplus0.17
At a glance
Updated 2026-08-24The shares listed at ₹120.00, a 5.26% move from the issue price. Gujarat Kidney is a Mainboard IPO with an issue size of ₹250.80 crore, proposed for listing on BSE, NSE. The offer opens on 22nd Dec 2025 and closes on 24th Dec 2025. The issue structure includes a fresh issue of ₹250.80 crore. The current listing schedule points to 30th Dec 2025.
Issue details
Listing atBSE, NSE
Issue typeBook Build Issue
Issue size₹250.80 Cr
Fresh issue₹250.80 Cr
Face value₹2
Price band₹108.00–₹114.00
Allotment26th Dec 2025
Listing30th Dec 2025
Listing performance
Full performance ↗Issue price₹114.00
Listing price₹120.00
Current price—
Listing gain5.26%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹1.50
GMP / upper price1.32%
Est. listing₹115.50
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens22nd Dec 2025
Closes24th Dec 2025
Allotment26th Dec 2025
Refund29th Dec 2025
Demat29th Dec 2025
Listing30th Dec 2025
Subscription demand
Full bidding ↗Total5.21×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 128 | ₹14,592 |
Company
Incorporated2019
Use of proceeds
| Object | Amount |
|---|---|
| Proposed acquisition of Parekhs Hospital at Ahmedabad. | ₹77.00 Cr |
| Part-payment of purchase consideration for the already acquired Ashwini Medical Centre. | ₹12.40 Cr |
| Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara. | ₹30.10 Cr |
| Buying robotics equipment for hospital Gujarat Kidney & Super Speciality hospital in Vadodara location. | ₹6.83 Cr |
| Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company | ₹1.20 Cr |
| Funding inorganic growth through unidentified acquisitions and general corporate purposes. | ₹87.44 Cr |
| Acquisition of additional shareholding in the subsidiary namely Harmony Medicare Pvt.Ltd. at Bharuch | ₹10.78 Cr |
| Issue Expenses | ₹25.06 Cr |
| Total | ₹250.80 Cr |
Financials
Full financials ↗31 Mar 2024
Assets20.53
Total Income5.48
EBITDA1.95
Profit After Tax1.71
NET Worth10.80
Reserves and Surplus10.60
Total Borrowing1.94
31 Mar 2025
Assets55.34
Total Income40.40
EBITDA16.55
Profit After Tax9.50
NET Worth25.71
Reserves and Surplus14.57
Total Borrowing3.88
30 Jun 2025
Assets61.59
Total Income15.27
EBITDA8.63
Profit After Tax5.40
NET Worth30.56
Reserves and Surplus19.42
Total Borrowing4.03
Trend chart₹ crore
KPIs
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 36.61% |
| ROCE | 37.65% |
| Debt / Equity | 0.15% |
| RoNW | 36.61% |
| PAT Margin | 23.61% |
| EBITDA Margin | 41.12% |
| Price to Book Value | 22.62 |
Valuation & shareholding
Pre-IPO EPS1.85
Post-IPO EPS2.74
Pre-IPO P/E61.62
Post-IPO P/E41.59
Promoter holding pre99.1%
Promoter holding post71.45%
Market cap₹898.81 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Proposed acquisition of Parekhs Hospital at Ahmedabad. | ₹77.00 Cr |
| Part-payment of purchase consideration for the already acquired Ashwini Medical Centre. | ₹12.40 Cr |
| Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara. | ₹30.10 Cr |
| Buying robotics equipment for hospital Gujarat Kidney & Super Speciality hospital in Vadodara location. | ₹6.83 Cr |
| Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company | ₹1.20 Cr |
| Funding inorganic growth through unidentified acquisitions and general corporate purposes. | ₹87.44 Cr |
| Acquisition of additional shareholding in the subsidiary namely Harmony Medicare Pvt.Ltd. at Bharuch | ₹10.78 Cr |
| Issue Expenses | ₹25.06 Cr |
| Total | ₹250.80 Cr |
Registrar & lead managers
Registrar
MUFG Intime India Pvt.Ltd.Lead managers
- Nirbhay Capital Services Pvt.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-24.